Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pengxiang Li

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Health Services Insights|May 5, 2017
Outcomes of Surgeries Performed in Physician Offices Compared With Ambulatory Surgery Centers and Hospital Outpatient Departments in FloridaRobert L Ohsfeldt, Pengxiang Li, John E Schneider, et al.
Computers in Human Behavior|May 1, 2023
The bright and dark sides of social media use during COVID-19 lockdown: Contrasting social media effects through social liability vs. social supportHichang Cho, Pengxiang Li, Annabel Ngien, et al.
Psychiatric Services (Washington, D.C.)|November 14, 2023
Out-of-Pocket Costs for Long-Acting Injectable and Oral Antipsychotics Among Medicare Patients With SchizophreniaJalpa A Doshi, Pengxiang Li, Zhi Geng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2017
Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer AgentsJalpa A Doshi, Pengxiang Li, Hairong Huo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
HSR26-253: Patient Assistance for Drug Cost Sharing: Highlighting the Variability Across Pharmaceutical Manufacturers of Specialty Oral Anticancer Medications for Blood CancersAnoosha Shukla, John K Lin, Pengxiang Li, et al.
JAMA|December 29, 2025
Specialty Oral Anticancer Prescription Fill Rates After Medicare Part D Cost-Sharing Changes in 2024John K Lin, Pengxiang Li, Xiudong Lei, et al.
JAMA Network Open|June 15, 2019
Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell CarcinomaPengxiang Li, Jordan Jahnke, Amy R Pettit, et al.
Cancer Medicine|December 2, 2017
Association of high cost sharing and targeted therapy initiation among elderly Medicare patients with metastatic renal cell carcinomaPengxiang Li, Yu-Ning Wong, Jordan Jahnke, et al.
Journal of Medical Economics|March 24, 2023
Antipsychotic utilization, healthcare resource use and costs, and quality of care among fee-for-service Medicare beneficiaries with schizophrenia in the United StatesPengxiang Li, Carmela Benson, Zhi Geng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
HSR26-253: Patient Assistance for Drug Cost Sharing: Highlighting the Variability Across Pharmaceutical Manufacturers of Specialty Oral Anticancer Medications for Blood CancersAnoosha Shukla, John K Lin, Pengxiang Li, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Health Services Insights|May 5, 2017
Outcomes of Surgeries Performed in Physician Offices Compared With Ambulatory Surgery Centers and Hospital Outpatient Departments in FloridaRobert L Ohsfeldt, Pengxiang Li, John E Schneider, et al.
Computers in Human Behavior|May 1, 2023
The bright and dark sides of social media use during COVID-19 lockdown: Contrasting social media effects through social liability vs. social supportHichang Cho, Pengxiang Li, Annabel Ngien, et al.
Psychiatric Services (Washington, D.C.)|November 14, 2023
Out-of-Pocket Costs for Long-Acting Injectable and Oral Antipsychotics Among Medicare Patients With SchizophreniaJalpa A Doshi, Pengxiang Li, Zhi Geng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2017
Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer AgentsJalpa A Doshi, Pengxiang Li, Hairong Huo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
HSR26-253: Patient Assistance for Drug Cost Sharing: Highlighting the Variability Across Pharmaceutical Manufacturers of Specialty Oral Anticancer Medications for Blood CancersAnoosha Shukla, John K Lin, Pengxiang Li, et al.
JAMA|December 29, 2025
Specialty Oral Anticancer Prescription Fill Rates After Medicare Part D Cost-Sharing Changes in 2024John K Lin, Pengxiang Li, Xiudong Lei, et al.
JAMA Network Open|June 15, 2019
Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell CarcinomaPengxiang Li, Jordan Jahnke, Amy R Pettit, et al.
Cancer Medicine|December 2, 2017
Association of high cost sharing and targeted therapy initiation among elderly Medicare patients with metastatic renal cell carcinomaPengxiang Li, Yu-Ning Wong, Jordan Jahnke, et al.
Journal of Medical Economics|March 24, 2023
Antipsychotic utilization, healthcare resource use and costs, and quality of care among fee-for-service Medicare beneficiaries with schizophrenia in the United StatesPengxiang Li, Carmela Benson, Zhi Geng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
HSR26-253: Patient Assistance for Drug Cost Sharing: Highlighting the Variability Across Pharmaceutical Manufacturers of Specialty Oral Anticancer Medications for Blood CancersAnoosha Shukla, John K Lin, Pengxiang Li, et al.
Pageof 12